Edition:
India

Chemours Co (CC.N)

CC.N on New York Stock Exchange

16.19USD
10 Dec 2019
Change (% chg)

-- (--)
Prev Close
$16.19
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
789,200
52-wk High
$41.57
52-wk Low
$11.72

Latest Key Developments (Source: Significant Developments)

Greenlight Capital Ups Share Stake In Brighthouse Financial, Chemours
Friday, 15 Nov 2019 

Nov 14 (Reuters) - Greenlight Capital Inc::GREENLIGHT CAPITAL INC UPS SHARE STAKE IN CHEMOURS CO BY 74.2 PERCENT TO 6.5 MILLION SHARES -SEC FILING.GREENLIGHT CAPITAL INC UPS SHARE STAKE IN BRIGHTHOUSE FINANCIAL BY 8.5 PERCENT TO 3.6 MILLION SHARES - SEC FILING.GREENLIGHT CAPITAL INC CUTS SHARE STAKE IN DILLARDS INC BY 25.7 PERCENT TO 297,170 CLASS A SHARES - SEC FILING.GREENLIGHT CAPITAL INC - CHANGE IN HOLDINGS ARE AS OF SEPTEMBER 30, 2019 AND COMPARED WITH THE PREVIOUS QUARTER ENDED AS OF JUNE 30, 2019.  Full Article

The Chemours Company Posts Q2 EPS Of $0.57
Friday, 2 Aug 2019 

Aug 1 (Reuters) - Chemours Co ::THE CHEMOURS COMPANY REPORTS SECOND QUARTER 2019 RESULTS.Q2 ADJUSTED EARNINGS PER SHARE $0.72.Q2 EARNINGS PER SHARE $0.57.Q2 SALES $1.4 BILLION VERSUS REFINITIV IBES ESTIMATE OF $1.5 BILLION.Q2 EARNINGS PER SHARE ESTIMATE $0.86 -- REFINITIV IBES DATA.REDUCED 2019 OUTLOOK FOR ADJUSTED EBITDA, ADJUSTED EPS, AND FREE CASH FLOW.NOW EXPECTS TO DELIVER 2019 ADJUSTED EBITDA WITHIN A RANGE OF $1.00 TO $1.15 BILLION.SEES EXPECTS 2019 ADJUSTED EPS OF BETWEEN $2.37 AND $3.08 PER SHARE.SEES 2019 CAPITAL EXPENDITURES ARE EXPECTED TO BE APPROXIMATELY $500 MILLION, WITH FREE CASH FLOW OF APPROXIMATELY $100 MILLION.FY2019 EARNINGS PER SHARE VIEW $3.90 -- REFINITIV IBES DATA.  Full Article

Chemours Announces Price Increase For Methylamines Products In North America
Wednesday, 28 Nov 2018 

Chemours Co ::CHEMOURS ANNOUNCES PRICE INCREASE FOR METHYLAMINES PRODUCTS IN NORTH AMERICA.CHEMOURS CO - PRICE INCREASE IS EFFECTIVE JANUARY 1, 2019.CHEMOURS CO - 10 PERCENT PRICE INCREASE FOR ALL METHYLAMINES, DIMETHYLFORMAMIDE, DIMETHYLACETAMIDE, DIMETHYL SULFATE PRODUCTS SOLD IN NORTH AMERICA.  Full Article

Dowdupont Says In Q2, Dupont Got Subpoena Expanding Scope To Any PFCs Discharged From Fayetteville Works Facility
Friday, 3 Aug 2018 

Aug 3 (Reuters) - DowDuPont Inc ::DOWDUPONT SAYS IN Q2 DUPONT GOT SUBPOENA EXPANDING SCOPE TO ANY PFCS DISCHARGED FROM FAYETTEVILLE WORKS FACILITY INTO CAPE FEAR RIVER - SEC FILING.  Full Article

Chemours Q2 Adjusted Earnings Per Share $1.71
Friday, 3 Aug 2018 

Chemours Co ::EXPECT FULL-YEAR 2018 ADJUSTED EBITDA IN TOP END OF RANGE, REAFFIRMED THREE-YEAR TARGETS.BOARD AUTHORIZED NEW $750 MILLION SHARE REPURCHASE PROGRAM AND INCREASED DIVIDEND TO $0.25 PER SHARE.THE CHEMOURS COMPANY REPORTS SECOND QUARTER 2018 RESULTS, DOUBLE DIGIT GROWTH ACROSS ALL KEY FINANCIAL METRICS, EPS UP 82 PERCENT WITH ADJUSTED EPS UP 99 PERCENT.Q2 ADJUSTED EARNINGS PER SHARE $1.71.Q2 EARNINGS PER SHARE $1.53.Q2 SALES $1.8 BILLION VERSUS I/B/E/S VIEW $1.82 BILLION.Q2 EARNINGS PER SHARE VIEW $1.59 -- THOMSON REUTERS I/B/E/S.BELIEVE 2018 EARNINGS WILL BE IN TOP END OF PREVIOUSLY ANNOUNCED RANGE.FY2018 EARNINGS PER SHARE VIEW $5.88 -- THOMSON REUTERS I/B/E/S.BOARD DECLARED A QUARTERLY CASH DIVIDEND OF $0.25 PER SHARE.BOARD AUTHORIZED A $750 MILLION SHARE REPURCHASE PLAN.  Full Article

Chemours Announces Commencement Of Public Offering Of Senior Notes
Monday, 21 May 2018 

May 21 (Reuters) - Chemours Co ::CHEMOURS ANNOUNCES COMMENCEMENT OF PUBLIC OFFERING OF SENIOR NOTES.CHEMOURS - NET PROCEEDS OF OFFERING TO BE USED TO FUND PURCHASE PRICE, ACCRUED, UNPAID INTEREST FOR UP TO $250 MILLION OF 6.625% SENIOR NOTES DUE 2023.CHEMOURS - NET PROCEEDS OF OFFERING ALSO TO BE USED TO FUND PURCHASE PRICE, ACCRUED, UNPAID INTEREST FOR ANY, ALL OF CO'S 6.125% SENIOR NOTES DUE 2023.  Full Article

Chemours Sees FY 2018 ADJ EPS At High End Of Previous Guidance Of $4.95 To $5.60
Tuesday, 27 Mar 2018 

March 26 (Reuters) - Chemours Co ::THE CHEMOURS COMPANY UPDATES 2018 OUTLOOK AND ANNOUNCES DATES FOR FIRST QUARTER 2018 EARNINGS RELEASE AND WEBCAST CONFERENCE CALL.CHEMOURS SEES FY 2018 ADJUSTED EARNINGS PER SHARE AT HIGH END OF PREVIOUS GUIDANCE OF $4.95 TO $5.60.CHEMOURS CO - SEES 2018 ADJUSTED EBITDA AT HIGH END OF PREVIOUSLY COMMUNICATED $1.7 BILLION TO $1.85 BILLION RANGE.CHEMOURS CO - ‍NOW EXPECTS EARNINGS TO BE IN TOP END OF ITS PREVIOUSLY ANNOUNCED RANGE​.CHEMOURS CO - ‍CURRENTLY EVALUATING IMPACT OF MORE FAVORABLE CONDITIONS TO LONGER-TERM TARGETS​.  Full Article

Greenlight made new bets on Chemours, Dillard's in second quarter-letter

BOSTON David Einhorn's hedge fund Greenlight Capital said on Thursday that it made new bets on chemical company Chemours , retailer Dillard's Inc. and gambling products company Scientific Games Corporation in second quarter.